Enzo Biochem Net Income

Enzo Biochem (ENZ) currently reports a net income of $-21M as of April 2025. That compares with $45M in the prior-year period — down 147.1% year over year. That is below the Healthcare sector average of $16B. Use the charts on this page to explore Enzo Biochem's net income history and peer comparisons.

Enzo Biochem's net income decreased from $45M to $-21M — a 147.1% year-over-year decrease (period ending April 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Enzo Biochem's net income of $-21M is lower than the Healthcare sector average of $16B. That is roughly 100.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Enzo Biochem reported $-21M in net income as of April 2025. That compares with $45M in the prior-year period — down 147.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $-21M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $16B. From there, open related valuation or income-statement pages for Enzo Biochem, and consider following ENZ for alerts when major investors trade the stock.